{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:56:44Z","timestamp":1781924204378,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008271","name":"LEO Pharma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.thromres.2020.09.021","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T02:54:50Z","timestamp":1600224890000},"page":"349-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8817-2912","authenticated-orcid":false,"given":"Victoria E.","family":"Castell\u00f3n Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro P\u00e9rez-","family":"Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L\u00f3pez","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana Canosa","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.thromres.2020.09.021_bb0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/jth.14305","article-title":"Management of venous thromboembolism in patients with cancer","volume":"16","author":"L\u00f3pez-N\u00fa\u00f1ez","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2020.09.021_bb0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00408-013-9485-1","article-title":"Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal study","volume":"191","author":"van Herk-Sukel","year":"2013","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.thromres.2020.09.021_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2014.07.017","article-title":"Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy","volume":"86","author":"Mellema","year":"2014","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.thromres.2020.09.021_bb0020","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.thromres.2020.09.021_bb0025","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1200\/JCO.2009.22.8197","article-title":"Venous thromboembolism in the hematologic malignancies","volume":"27","author":"Falanga","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.thromres.2020.09.021_bb0030","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1002\/cncr.26597","article-title":"Risk assessment models for cancer-associated venous thromboembolism","volume":"118","author":"Dutia","year":"2012","journal-title":"Cancer."},{"issue":"2\u20133","key":"10.1016\/j.thromres.2020.09.021_bb0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10555-014-9500-x","article-title":"Clinical models and biochemical predictors of VTE in lung cancer","volume":"33","author":"Roselli","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.thromres.2020.09.021_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14824","article-title":"IPDMA heparin use in cancer patients research group. The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis","author":"van Es","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2020.09.021_bb0045","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jth.13378","article-title":"Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer","volume":"14","author":"Mansfield","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2020.09.021_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","article-title":"A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score","volume":"7","author":"Verso","year":"2012","journal-title":"Intern. Emerg. Med."},{"issue":"41","key":"10.1016\/j.thromres.2020.09.021_bb0055","first-page":"2084","article-title":"Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?","volume":"138","author":"Pelzer","year":"2013","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"24","key":"10.1016\/j.thromres.2020.09.021_bb0060","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2020.09.021_bb0065","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1161\/01.CIR.88.3.1166","article-title":"Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart","volume":"88","author":"L\u00f3pez Farr\u00e9","year":"1993","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.thromres.2020.09.021_bb0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bjp.0706340","article-title":"Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery","volume":"146","author":"Molero","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.thromres.2020.09.021_bb0075","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat. Med."},{"issue":"6","key":"10.1016\/j.thromres.2020.09.021_bb0080","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH13-11-0956","article-title":"Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer","volume":"111","author":"Lee","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2020.09.021_bb0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1538-7836.2008.02908.x","article-title":"The incidence of venous thromboembolism among patients with primary lung cancer","volume":"6","author":"Chew","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2020.09.021_bb0090","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1111\/j.1538-7836.2012.04880.x","article-title":"Cigarette smoking and the risk of venous thromboembolism: the Troms\u00f8 study","volume":"10","author":"Enga","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"6398","key":"10.1016\/j.thromres.2020.09.021_bb0095","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/359848a0","article-title":"Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets","volume":"359","author":"Palabrica","year":"1992","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.thromres.2020.09.021_bb0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2015-01-624023","article-title":"P-selectin promotes neutrophil extracellular trap formation in mice","volume":"126","author":"Etulain","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2020.09.021_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.12778","article-title":"Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS)","volume":"13","author":"Pabinger","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2020.09.021_bb0110","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2008-02-142422","article-title":"High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and thrombosis study (CATS)","volume":"112","author":"Ay","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2020.09.021_bb0115","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/jth.14484","article-title":"Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer","volume":"17","author":"Grilz","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.09.021_bb0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.thromres.2016.10.020","article-title":"A systematic review of biomarkers for the prediction of thromboembolism in lung cancer - results, practical issues and proposed strategies for future risk prediction models","volume":"148","author":"Alexander","year":"2016","journal-title":"Thromb. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2020.09.021_bb0125","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0049-3848(16)30094-9","article-title":"Microparticles and cancer thrombosis in animal models","volume":"140","author":"Mege","year":"2016","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2020.09.021_bb0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/cvr\/cvv154","article-title":"Selectins: initiators of leucocyte adhesion and signalling at the vascular wall","volume":"107","author":"McEver","year":"2015","journal-title":"Cardiovasc. Res."},{"issue":"24","key":"10.1016\/j.thromres.2020.09.021_bb0135","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","article-title":"The adhesion molecule P-selectin and cardiovascular disease","volume":"24","author":"Blann","year":"2003","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.thromres.2020.09.021_bb0140","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1002\/cncr.11432","article-title":"Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance","volume":"97","author":"Buccheri","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.thromres.2020.09.021_bb0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jth.14343","article-title":"High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor","volume":"17","author":"Rietveld","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2020.09.021_bb0150","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/ATVBAHA.109.190827","article-title":"High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study","volume":"29","author":"Vormittag","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2020.09.021_bb0155","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.thromres.2015.10.004","article-title":"Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis","volume":"136","author":"Tafur","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.09.021_bb0160","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820305259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820305259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:45:43Z","timestamp":1758735943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820305259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"alternative-id":["S0049384820305259"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.09.021","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}